Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment

This study has been withdrawn prior to enrollment.

(No enrollment.)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT00006091

First received: August 3, 2000

Last updated: October 5, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	January 2002
Primary Completion Date:	January 2002 (Final data collection date for primary outcome measure)